Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Micheline Pha

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of the American Academy of Dermatology|November 22, 2020
Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patientsRaphael Aitmehdi, Laurent Arnaud, Camille Francès, et al.
European Cytokine Network|June 13, 2025
Serum interferon-beta level determined by an ultrasensitive electrochemiluminescence immunoassay is increased in clinically active and inactive systemic lupus erythematosusKarim Dorgham, Omaira Da Mata Jardin, Clara Mellot, et al.
Lupus|February 11, 2026
Phenotypic clustering of cardiovascular risk profiles in systemic lupus erythematosusLévi-Dan Azoulay, Nadjia Kachenoura, Samia Boussouar, et al.
Lupus Science & Medicine|April 21, 2026
Serum lipidomic and metabolomic signatures link epicardial adipose tissue to cardiovascular diseases in SLE: a post-hoc analysisLevi-Dan Azoulay, Fanny Urbain, Maharajah Ponnaiah, et al.
Annals of the Rheumatic Diseases|October 5, 2021
BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosusQuentin Moyon, Delphine Sterlin, Makoto Miyara, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2018
Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-αAlexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, et al.
European Journal of Preventive Cardiology|August 29, 2025
Prognostic value of CT-derived epicardial adipose tissue volume over coronary artery calcium in systemic lupus erythematosusLévi-Dan Azoulay, Nadjia Kachenoura, Samia Boussouar, et al.
Rheumatology (Oxford, England)|April 25, 2025
Indications, efficacy, safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohortJade Cognard, Christine Pietrement, Audrey Laurent, et al.
Rheumatology (Oxford, England)|September 9, 2020
Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study)Julie Chezel, Nathalie Costedoat-Chalumeau, Cedric Laouénan, et al.
Journal of Internal Medicine|April 4, 2022
Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort studyClémence David, Nathalie Costedoat-Chalumeau, Drifa Belhadi, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of the American Academy of Dermatology|November 22, 2020
Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patientsRaphael Aitmehdi, Laurent Arnaud, Camille Francès, et al.
European Cytokine Network|June 13, 2025
Serum interferon-beta level determined by an ultrasensitive electrochemiluminescence immunoassay is increased in clinically active and inactive systemic lupus erythematosusKarim Dorgham, Omaira Da Mata Jardin, Clara Mellot, et al.
Lupus|February 11, 2026
Phenotypic clustering of cardiovascular risk profiles in systemic lupus erythematosusLévi-Dan Azoulay, Nadjia Kachenoura, Samia Boussouar, et al.
Lupus Science & Medicine|April 21, 2026
Serum lipidomic and metabolomic signatures link epicardial adipose tissue to cardiovascular diseases in SLE: a post-hoc analysisLevi-Dan Azoulay, Fanny Urbain, Maharajah Ponnaiah, et al.
Annals of the Rheumatic Diseases|October 5, 2021
BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosusQuentin Moyon, Delphine Sterlin, Makoto Miyara, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2018
Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-αAlexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, et al.
European Journal of Preventive Cardiology|August 29, 2025
Prognostic value of CT-derived epicardial adipose tissue volume over coronary artery calcium in systemic lupus erythematosusLévi-Dan Azoulay, Nadjia Kachenoura, Samia Boussouar, et al.
Rheumatology (Oxford, England)|April 25, 2025
Indications, efficacy, safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohortJade Cognard, Christine Pietrement, Audrey Laurent, et al.
Rheumatology (Oxford, England)|September 9, 2020
Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study)Julie Chezel, Nathalie Costedoat-Chalumeau, Cedric Laouénan, et al.
Journal of Internal Medicine|April 4, 2022
Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort studyClémence David, Nathalie Costedoat-Chalumeau, Drifa Belhadi, et al.
Pageof 5